Suppr超能文献

健康供体粪便移植治疗对皮质类固醇无反应的严重酒精性肝炎

Healthy donor faecal transplant for corticosteroid non-responsive severe alcoholic hepatitis.

作者信息

Philips Cyriac Abby, Phadke Nikhil, Ganesan Karthik, Augustine Philip

机构信息

The Liver Unit, Ernakulam Medical Centre, Kochi, Kerala, India.

Molecular, Cellular and Developmental Biology, Genepath Dx, Pune, Maharashtra, India.

出版信息

BMJ Case Rep. 2017 Nov 8;2017:bcr-2017-222310. doi: 10.1136/bcr-2017-222310.

Abstract

Patients with severe alcoholic hepatitis (SAH) have high mortality in the presence of steroid unresponsiveness in the absence of clear treatment recommendations. Liver transplantation is the curative option in such cases but is controversial in the wake of severe infections, post-transplant recidivism and long waiting on deceased donor listing. Animal and human studies have shed light on the beneficial effects of gut microbiota modulation in alcoholic liver disease. We present the first report of faecal microbiota transplantation (FMT) in a steroid non-responder in whom, clinical, biochemical and liver disease severity scores improved post-FMT and demonstrate distinct bacterial population changes pre-FMT and post-FMT. Healthy donor FMT could be safe and efficacious in SAH not responding to corticosteroid treatment, as a bridge to liver transplantation (LT) or in candidates who are unwilling or not ideal for LT for improvement in short-term transplant free survival. Larger controlled studies are required for confirmation.

摘要

在缺乏明确治疗建议的情况下,重症酒精性肝炎(SAH)患者在对类固醇无反应时死亡率很高。肝移植是此类病例的治愈选择,但在严重感染、移植后复发以及在已故供体名单上长时间等待的情况下存在争议。动物和人体研究揭示了肠道微生物群调节在酒精性肝病中的有益作用。我们首次报告了粪便微生物群移植(FMT)用于一名对类固醇无反应的患者,该患者在FMT后临床、生化指标及肝病严重程度评分均有所改善,并展示了FMT前后不同的细菌种群变化。健康供体FMT对于对皮质类固醇治疗无反应的SAH患者可能是安全有效的,可作为肝移植(LT)的桥梁,或用于那些不愿意接受LT或不适合LT的患者,以改善短期无移植生存期。需要更大规模的对照研究来证实这一点。

相似文献

1
Healthy donor faecal transplant for corticosteroid non-responsive severe alcoholic hepatitis.
BMJ Case Rep. 2017 Nov 8;2017:bcr-2017-222310. doi: 10.1136/bcr-2017-222310.
2
Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis.
Indian J Gastroenterol. 2018 May;37(3):215-225. doi: 10.1007/s12664-018-0859-4. Epub 2018 Jun 21.
4
Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial.
Hepatol Int. 2023 Feb;17(1):249-261. doi: 10.1007/s12072-022-10438-0. Epub 2022 Dec 5.
5
Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial.
Hepatol Int. 2022 Apr;16(2):433-446. doi: 10.1007/s12072-022-10312-z. Epub 2022 Mar 28.
6
Fecal microbiota transplantation in alcohol related liver diseases.
Clin Mol Hepatol. 2020 Jul;26(3):294-301. doi: 10.3350/cmh.2020.0057. Epub 2020 Jun 23.
7
Role of liver transplantation in severe alcoholic hepatitis.
Clin Mol Hepatol. 2018 Mar;24(1):43-50. doi: 10.3350/cmh.2017.0027. Epub 2018 Jan 10.
8
New paradigms in management of alcoholic hepatitis: a review.
Hepatol Int. 2017 May;11(3):255-267. doi: 10.1007/s12072-017-9790-5. Epub 2017 Feb 28.
9
Diagnosis and management of alcoholic liver disease.
J Dig Dis. 2011 Aug;12(4):257-62. doi: 10.1111/j.1751-2980.2010.00470.x.
10
Liver transplantation in alcoholic liver disease current status and controversies.
World J Gastroenterol. 2013 Sep 28;19(36):5953-63. doi: 10.3748/wjg.v19.i36.5953.

引用本文的文献

1
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease.
World J Gastroenterol. 2025 Jul 28;31(28):105089. doi: 10.3748/wjg.v31.i28.105089.
2
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma.
Front Immunol. 2025 Feb 25;16:1526967. doi: 10.3389/fimmu.2025.1526967. eCollection 2025.
4
Alcohol-associated liver disease: Natural history, management and novel targeted therapies.
Clin Mol Hepatol. 2025 Feb;31(Suppl):S112-S133. doi: 10.3350/cmh.2024.0709. Epub 2024 Oct 31.
6
Roles of Gut Microbiota in Alcoholic Liver Disease.
Int J Gen Med. 2023 Aug 23;16:3735-3746. doi: 10.2147/IJGM.S420195. eCollection 2023.
7
Research Progress of Fecal Microbiota Transplantation in Liver Diseases.
J Clin Med. 2023 Feb 20;12(4):1683. doi: 10.3390/jcm12041683.
8
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment.
World J Hepatol. 2022 Jul 27;14(7):1319-1332. doi: 10.4254/wjh.v14.i7.1319.
9
Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases.
Chin Med J (Engl). 2022 Aug 20;135(16):1927-1939. doi: 10.1097/CM9.0000000000002339.
10
Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review.
Semin Liver Dis. 2021 Nov;41(4):495-506. doi: 10.1055/s-0041-1732319. Epub 2021 Jul 14.

本文引用的文献

1
Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.
Hepatology. 2017 Dec;66(6):1727-1738. doi: 10.1002/hep.29306. Epub 2017 Oct 30.
2
Emerging concepts in alcoholic hepatitis.
World J Hepatol. 2017 Apr 28;9(12):567-585. doi: 10.4254/wjh.v9.i12.567.
3
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
J Hepatol. 2017 Apr;66(4):806-815. doi: 10.1016/j.jhep.2016.11.008. Epub 2016 Nov 25.
4
Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study.
Clin Gastroenterol Hepatol. 2017 Apr;15(4):600-602. doi: 10.1016/j.cgh.2016.10.029. Epub 2016 Nov 2.
5
Durable coexistence of donor and recipient strains after fecal microbiota transplantation.
Science. 2016 Apr 29;352(6285):586-9. doi: 10.1126/science.aad8852.
6
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.
Gut. 2016 May;65(5):830-9. doi: 10.1136/gutjnl-2015-310585. Epub 2015 Dec 7.
7
Diagnosis and management of alcoholic hepatitis.
Clin Liver Dis. 2012 Nov;16(4):717-36. doi: 10.1016/j.cld.2012.08.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验